UBS Group’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

UBS Group’s Portfolio IBBQ Stock Details IBBQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,326	Closed	-$38.4K	–	10707
2026 Q1	$38.4K	Buy	+1,326	New	+$38.6K	﹤0.01%	7537
2025 Q4	–	Sell	-51	Closed	-$1.24K	–	10817
2025 Q3	$1.24K	Buy	+51	New	+$1.17K	﹤0.01%	9399
2025 Q2	–	Sell	-145	Closed	-$3.07K	–	10517
2025 Q1	$3.07K	Buy	+145	New	+$3.22K	﹤0.01%	9252
2024 Q4	–	Sell	-348	Closed	-$8.28K	–	10136
2024 Q3	$8.28K	Buy	+348	New	+$8.31K	﹤0.01%	7846
2023 Q4	–	Sell	-205	Closed	-$4.06K	–	9566
2023 Q3	$4.06K	Sell	205 -1,619	-89%	-$33K	﹤0.01%	7479
2023 Q2	$37.3K	Buy	+1,824	New	+$38.2K	﹤0.01%	6622
2023 Q1	–	Sell	-450	Closed	-$9.49K	–	9928
2022 Q4	$9.49K	Buy	+450	New	+$9.31K	﹤0.01%	8647
2022 Q3	–	Sell	-170	Closed	-$3K	–	10595
2022 Q2	$3K	Sell	170 -1,084	-86%	-$20.7K	﹤0.01%	9321
2022 Q1	$26K	Buy	1,254 +905	+259%	+$18.8K	﹤0.01%	7142
2021 Q4	$8K	Buy	+349	New	+$8.51K	﹤0.01%	9036

Other funds holding IBBQ

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

WMS Group Folsom, Louisiana $77.5M AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

IAA

Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return

KAM

Knightsbridge Asset Management Newport Beach, California $762M AUM 59.13% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

CFA

Churchill Financial Advisors Louisville, Kentucky $519M AUM

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

UBS Group's IBBQ Position: Q2 2026 in Review

UBS Group sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q2 2026, closing a stake of 1,326 shares — an estimated $38.4K sold.

UBS Group first reported a position in IBBQ in Q4 2021 and held it in 10 quarters. The position peaked at $38.4K in Q1 2026. 35 funds tracked by Wall St. Rank hold IBBQ as of Q2 2026.

UBS Group reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
UBS Group sold 1,326 Invesco NASDAQ Biotechnology ETF shares in Q2 2026, an estimated $38.4K.
UBS Group first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2021 and held it in 10 quarters.
UBS Group's Invesco NASDAQ Biotechnology ETF position peaked at $38.4K in Q1 2026.
35 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.